18145364. SYSTEMS AND METHODS FOR RESTORING BLOOD VESSEL PATENCY simplified abstract (Covidien LP)
Contents
SYSTEMS AND METHODS FOR RESTORING BLOOD VESSEL PATENCY
Organization Name
Inventor(s)
Onnik E. Tchulluian of Costa Mesa CA (US)
Ramesh V. Marrey of Mission Viejo CA (US)
SYSTEMS AND METHODS FOR RESTORING BLOOD VESSEL PATENCY - A simplified explanation of the abstract
This abstract first appeared for US patent application 18145364 titled 'SYSTEMS AND METHODS FOR RESTORING BLOOD VESSEL PATENCY
The patent application describes a treatment system for vascular defects that can be used for mechanical thrombectomy and deployment of an expandable device to treat intracranial atherosclerotic disease (ICAD).
- The treatment system includes a delivery catheter with an expandable member for ICAD treatment, such as a balloon or balloon-mounted stent.
- A thrombectomy assembly consists of a mechanical thrombectomy device, like a stent retriever, attached to a core member within the delivery catheter.
- The thrombectomy device can be advanced beyond the catheter's end to engage clot material, while the expandable member can be deployed for ICAD treatment.
Potential Applications: - Treatment of vascular defects - Mechanical thrombectomy for clot removal - Deployment of expandable devices for ICAD treatment
Problems Solved: - Addressing vascular defects - Removing clot material effectively - Treating ICAD with precision
Benefits: - Comprehensive treatment system - Versatile for different vascular issues - Minimally invasive procedures
Commercial Applications: Title: Innovative Treatment System for Vascular Defects This technology can be utilized in hospitals, clinics, and specialized medical facilities for the treatment of various vascular conditions, potentially leading to improved patient outcomes and reduced healthcare costs.
Questions about the technology: 1. How does this treatment system compare to traditional methods for vascular defect treatment? - The treatment system offers a more comprehensive approach by combining mechanical thrombectomy and expandable device deployment in a single system. 2. What are the potential risks associated with using this treatment system? - Risks may include complications during device deployment or thrombectomy procedures, which should be carefully managed by trained medical professionals.
Original Abstract Submitted
A single treatment system for vascular defects can be configured for use in removing clot material via mechanical thrombectomy and/or for deployment of an expandable device at a lesion to treat intracranial atherosclerotic disease (ICAD). Such a treatment system can include a delivery catheter carrying an expandable member configured to be deployed for treatment of ICAD, such as a balloon or balloon-mounted stent. A thrombectomy assembly includes a mechanical thrombectomy device (e.g., a stent retriever) coupled to the distal end of a core member that is slidably disposed within the delivery catheter lumen. In operation, the thrombectomy device can be slidably advanced beyond a distal end of the delivery catheter lumen, where the thrombectomy device can expand and engage clot material. Additionally or alternatively, the expandable member carried by the delivery catheter can be deployed (e.g., expanded into apposition with the vessel wall) for treatment of ICAD.
